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U.S. Environmental Protection Agency 	   12-P-0162
December 29, 2011Office of Inspector General 
At a Glance
Why We Did This Review 
The purpose of this review was 
to determine how effectively 
the U.S. Environmental 
Protection Agency (EPA) is 
managing the human health and 
environmental risks of 
nanomaterials.
Background 
Nanomaterials are currently
used in a wide variety of 
applications, including
consumer products, health care, 
transportation, energy, and 
agriculture. The Agency
considers nanomaterials as 
chemical substances that are 
controlled at the scale of 
approximately one-billionth of 
a meter. EPA has the authority, 
through several environmental 
statutes, to regulate 
nanomaterials. Although the 
development of nanomaterials 
and nanomaterial-enhanced 
products is expanding rapidly, 
the health implications of 
nanomaterials have not yet
been determined.
For further information, contact 
our Office of Congressional and 
Public Affairs at (202) 566-2391.
The full report is at: 
www.epa.gov/oig/reports/2012/ 
20121229-12-P-0162.pdf
EPA Needs to Manage Nanomaterial Risks More Effectively
 What We Found 
We found that EPA does not currently have sufficient information or processes to
effectively manage the human health and environmental risks of nanomaterials. 
EPA has the statutory authority to regulate nanomaterials but currently lacks the 
environmental and human health exposure and toxicological data to do so 
effectively. The Agency proposed a policy under the Federal Insecticide, 
Fungicide, and Rodenticide Act to identify new pesticides being registered with 
nanoscale materials. After minimal industry participation in a voluntary data 
collection program, the Agency has proposed mandatory reporting rules for 
nanomaterials under the Federal Insecticide, Fungicide, and Rodenticide Act, and 
is also developing proposed rules under the Toxic Substances Control Act.
However, even if mandatory reporting rules are approved, the effectiveness of 
EPA’s management of nanomaterials remains in question for a number of 
reasons: 
 Program offices do not have a formal process to coordinate the 
dissemination and utilization of the potentially mandated information. 
 EPA is not communicating an overall message to external stakeholders 
regarding policy changes and the risks of nanomaterials. 
 EPA proposes to regulate nanomaterials as chemicals and its success in 
managing nanomaterials will be linked to the existing limitations of those 
applicable statutes. 
 EPA’s management of nanomaterials is limited by lack of risk 
information and reliance on industry-submitted data. 
These issues present significant barriers to effective nanomaterial management 
when combined with existing resource challenges. If EPA does not improve its 
internal processes and develop a clear and consistent stakeholder communication 
process, the Agency will not be able to assure that it is effectively managing 
nanomaterial risks. 
What We Recommend 
We recommend that the Assistant Administrator for Chemical Safety and 
Pollution Prevention develop a process to assure effective dissemination and 
coordination of nanomaterial information across relevant program offices. The 
Agency agreed with our recommendation and provided a corrective action plan 
with milestone dates. This recommendation is open with agreed-to actions 
pending.
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
WASHINGTON, D.C. 20460
THE INSPECTOR GENERAL 
December 29, 2011 
MEMORANDUM
SUBJECT:	 EPA Needs to Manage Nanomaterial Risks More Effectively 
Report No. 12-P-0162 
FROM:	 Arthur A. Elkins, Jr. 
Inspector General 
TO:	 Jim Jones 
Acting Assistant Administrator for Chemical Safety and Pollution Prevention  
This is our report on the subject evaluation conducted by the Office of Inspector General (OIG) 
of the U.S. Environmental Protection Agency (EPA). This report contains findings that describe 
the problems the OIG has identified and corrective actions the OIG recommends. This report 
represents the opinion of the OIG and does not necessarily represent the final EPA position. 
Final determinations on matters in this report will be made by EPA managers in accordance with 
established audit resolution procedures.  
Action Required 
Because you have provided a corrective action plan with milestone dates, you are not required 
to provide a written response to this report. Should you choose to provide a response, your 
response will be posted on the OIG’s public website, along with our memorandum commenting 
on your response. Your response should be provided as an Adobe PDF file that complies with 
the accessibility requirements of Section 508 of the Rehabilitation Act of 1973, as amended. 
The final response should not contain data that you do not want to be released to the public; if 
your response contains such data, you should identify the data for redaction or removal. We
have no objections to the further release of this report to the public. We will post this report to 
our website at http://www.epa.gov/oig. 
If you or your staff have any questions, please contact Wade Najjum at (202) 566-0827 or 
najjum.wade@epa.gov; Jeffrey Harris at (202) 566-0831 or harris.jeffrey@epa.gov; or Lauretta 
Joseph, Project Manager, at (212) 637-3049 or ansah.lauretta@epa.gov. 
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Chapter 1

Introduction 
Purpose
The purpose of this review was to determine how effectively the U.S. 
Environmental Protection Agency (EPA) is managing the human health and 
environmental risks of nanomaterials. 
Background 
Nanomaterials encompass a wide range of substances based on the understanding 
and control of matter at the scale of nanometers—the equivalent of one-billionth 
of a meter. Nanomaterials are nanoscale materials or materials that contain 
nanoscale structures internally or on their surfaces. Nanomaterials are currently 
used in a wide variety of applications, including consumer products, health care, 
transportation, energy, and agriculture. While some nanomaterials can occur 
naturally, this report focuses on intentionally manufactured nanomaterials. 
Figure 1 illustrates the relative size of nanomaterials. 
Figure 1: Size and scale of nanomaterials 
Source: National Nanotechnology Institute website.
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Though the development of nanomaterials and nanomaterials-enhanced products 
is expanding rapidly, the health or environmental implications of nanomaterials 
have not yet been determined.1 Research has shown that exposure to 
nanomaterials may produce effects that differ from those observed with 
conventionally scaled materials. Some nanomaterials may cross the human blood-
brain or placental barrier in ways that larger particles cannot. 2,3 
The many applications of nanomaterials present new opportunities to improve 
products, processes, and technologies. Some of these applications may improve 
how contaminants are measured, monitored, managed, and minimized in the 
environment. However, there also exists the potential for exposures to 
nanomaterials during product manufacturing, use, and/or at the end of the product 
life cycle through recycling, landfills, and waste incineration. Depending on the 
individual properties, nanomaterials may be able to enter the human body through 
the skin, through ingestion, and through inhalation. For example, because some
carbon nanotubes resemble asbestos fibers, researchers are questioning whether 
they may lead to diseases such as mesothelioma. Further, research has shown that, 
when combined with ultraviolet light and sweat, nanotitanium dioxide in 
sunscreen is capable of altering proteins in the skin. More research is needed to 
determine whether this may cause skin diseases.
Risks to public health are dependent, in part, on exposure. Public exposure has 
likely been limited to date. Table 1 illustrates examples of commercial 
applications of nanomaterials and their respective potential routes of exposure to 
the public. 
1 EPA's website states that in some cases there may be beneficial characteristics of nanomaterials when used for 

drug delivery and disease treatments. EPA acknowledges that this characteristic could also result in unintended 

impacts for manufactured nanomaterials not designed for disease therapies. 

2 P. Wick, A. Malek, P. Manser, D. Meili, X. Maeder-Althaus, L. Diener, P.A. Diener, A. Zisch, H.F. Krug, U. von 

Mandach, “Barrier Capacity of Human Placenta for Nanosized Materials”, Environmental Health Perspectives, vol. 

118, no. 3, pp. 432-6, March 2010. 

3 Panyala, NR; Pena-Mendez, EM; Havel, J. (2008). Silver or silver nanoparticles: a hazardous threat to the 

environment and human health? Journal of Applied Biomedicine, 6(3): 117–29. 
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Table 1:  Consumer exposure for several types of nanomaterial products
Product type Release and/or exposure source Exposedpopulation
Potential exposure
route
Product application by consumer to skin Consumer Dermal
Sunscreen  
Release by consumer to water supply (e.g., 
washing with soap and water)
General
population Ingestion
Disposal of sunscreen container with residual 
sunscreen after use to landfill or incineration
General
population Inhalation or ingestion
Paints and 
coating Weathering, disposal
Consumers, 
general population
Dermal, inhalation or 
ingestion
Clothing Wear, washing, disposal Consumers, general population
Dermal, inhalation, 
ingestion from surface 
or ground water 
Electronics Release at end of life or recycling stage Consumers, general population
Dermal, ingestion from 
surface or ground 
water
Sporting goods Release at end of life or recycling stage Consumers, general population
Dermal, inhalation, 
ingestion from surface 
or ground water 
Source: EPA, Nanotechnology White Paper, 2007. 
In 2010, federal support of nanomaterial research and development totaled 
$1.9 billion. Federal research and development efforts are coordinated by the 
National Nanotechnology Initiative (NNI). The NNI creates a framework for 
shared goals, priorities, and strategies for each federal agency to leverage the 
resources of all participating agencies. Along with 25 other federal agencies, EPA 
works with the NNI to conduct research on nanomaterials. 
EPA is one of nine federal agencies that dedicate funding to identify any potential 
adverse effects of nanomaterials and the risks these nanomaterials pose to human 
health and the environment. Each size, formulation, and application of a 
nanomaterial used as a pesticide or industrial chemical could potentially introduce 
a unique risk that EPA is required to understand and address.  
EPA’s Approach to Managing Nanomaterials 
EPA has the statutory authority to regulate nanomaterials during various stages of 
their production, use, and disposal. EPA can regulate nanomaterials during their 
manufacture, formulation, distribution in commerce, use, and/or disposal through 
the Toxic Substances Control Act (TSCA). EPA can regulate nanomaterials in 
pesticides through the Federal Insecticide, Fungicide, and Rodenticide Act 
(FIFRA), the authority under which EPA regulates the sale, distribution, and use 
of pesticide products in the United States. EPA can regulate nanomaterials 
released into the environment using the Clean Air Act; the Clean Water Act; the 
Comprehensive Environmental Response, Compensation and Liability Act; or the 
Resource Conservation and Recovery Act.  
EPA oversees the management of nanomaterial products. The Office of Chemical 
Safety and Pollution Prevention (OCSPP) stated that since 2005 it has received 
12-P-0162      3
    
                                                                                                                                             
 
 
 
  
 
   
 
 
 
 
 
 
 
 
 
 
and reviewed over 120 new chemical notices under TSCA for nanoscale 
materials, including carbon nanotubes. EPA’s management of nanomaterials 
under TSCA has evolved from a voluntary approach to a regulatory approach. In 
January 2008, EPA began collecting data from manufacturers using the voluntary 
Nanoscale Materials Stewardship Program (NMSP). EPA sought information on 
production, importation, and use; exposures; risk management practices; hazards; 
pollution prevention; and physical and chemical properties. EPA scientists 
intended to use data collected through this program, where appropriate, to aid in 
determining how and whether certain nanoscale materials or categories of
nanoscale materials present risks to human health and the environment. Although 
29 companies provided data that described or identified 123 nanomaterials, only 4 
companies were willing to participate in the portion of the program that 
encouraged them to sponsor the development of test data and provide that 
information to EPA. Based on the limited response to the program, EPA 
discontinued the NMSP in December 2009 and began developing regulatory 
approaches under Sections 5 and 8(a) of TSCA to collect nanomaterial data from
manufacturers of industrial chemicals.  
As shown in table 2, EPA is developing proposals for new data reporting 
requirements for FIFRA and TSCA. In July 2010, EPA submitted a request for a 
modification of FIFRA to the Office of Management and Budget (OMB). This 
submission sought to clarify the information collection ability of FIFRA 
regulations by including a description of nanomaterials in the policy, which would 
require manufacturers to submit more nano-specific data. In October 2010, EPA 
submitted a proposed TSCA revision to OMB. Under this proposal, any chemical 
substance from 1 to 100 nanometers will be subject to TSCA’s Significant New 
Use Rule (SNUR). This regulatory revision treats the nanomaterial as a new 
chemical and requires submission of data to EPA at least 90 days prior to 
commencing manufacture of these types of materials. 
 On June 17, 2011, EPA issued a Federal Register notice (76 FR 35383) seeking 
comments on how the Agency could use FIFRA Section 6(a)(2) or FIFRA 
Section 3(c)(2)(B) to gain information on what nanoscale materials are in
pesticide products. The notice also proposed a policy of classifying any 
application for registration of a pesticide product containing nanoscale material as 
an application for a “new” active or inert ingredient. 
12-P-0162      4
    
                                                                                                                                             
 
 
  
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
  
 
 
 
  
 
 
    
Table 2: New and existing regulations affecting nanomaterials
Regulation Description Status 
TSCA 5(a)(2) 
Nanomaterial SNUR
This change under TSCA would require that production of certain 
new nanoscale materials would constitute a significant new use 
of a chemical substance. Manufacturers must notify EPA at least 
90 days before starting production to provide EPA the 
opportunity to evaluate the intended use and, if necessary, to
prohibit or limit its use.  
Awaiting OMB approval
TSCA 8(a) 
Information Gathering 
This change under TSCA would require that persons who 
manufacture nanomaterials already in commerce notify EPA of 
information including production volume, methods of 
manufacture and processing, exposure and release information, 
and available health and safety data. 
Awaiting OMB approval
TSCA Section 5 New
Chemical Review
OCSPP stated that since 2005 it has received and reviewed over 
120 new chemical notices under TSCA for nanoscale materials, 
including carbon nanotubes. The Agency has taken a number of 
actions to control and limit exposures to these chemicals utilizing 
its authority under TSCA Sections 5(e) and 5(a) (2). 
Ongoing
FIFRA
6(a)(2) or 3(c)(2)(b)  
EPA issued a Federal Register notice on June 17, 2011, seeking 
comments on how the Agency could use FIFRA Section 6(a)(2) 
or FIFRA Section 3(c)(2)(B) to gain information on what 
nanoscale materials are in pesticide products. The notice also 
proposed a policy of classifying any application for registration of 
a pesticide product containing nanoscale material as an 
application for a “new” active or inert ingredient.  
Proposal currently
undergoing revisions by
EPA 
Source: OIG analysis.
Until the TSCA and FIFRA reporting requirements are complete, EPA will 
continue to lack the information to determine how and whether certain nanoscale 
materials or categories of nanoscale materials present risks to human health and 
the environment. 
EPA has determined that nanomaterials will be regulated under existing statutes 
for chemicals. Therefore, EPA’s effectiveness in managing nanomaterials will 
depend upon the effectiveness of its existing regulatory frameworks under FIFRA 
and TSCA. In our 2010 evaluation of TSCA’s New Chemicals Program, we 
identified a number of shortcomings: 
	 The program was limited by an absence of toxicity testing and 
environmental fate data, and a reliance on modeling, as TSCA does not 
require upfront testing. Because EPA depends on information reported by
industry, it can initially fail to identify chemical risks not self-disclosed by 
manufacturers. 
	 The program was limited by TSCA’s requirement to protect claims of 
confidential business information (CBI) on industry data submissions. The 
report stated that the Office of Pollution Protection and Toxics (OPPT) 
Chief of TSCA Security Staff estimated that up to 90 percent of TSCA 
premanufacture notices contain claims of CBI. Excessive CBI 
12-P-0162      5
    
                                                                                                                                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
     
         
designations inhibit independent peer reviews, oversight by external 
parties, and information sharing across EPA offices. 
Program Office Roles and Authority to Regulate Nanomaterials
The majority of EPA’s nanomaterial funding has been appropriated to the Office 
of Research and Development (ORD) to conduct research on nanomaterials. 
According to the Office of Chemical Safety and Pollution Prevention, it was the 
first to regulate nanomaterials based on the new chemical requirements under 
TSCA Section 5(e).   
Office of Research and Development 
ORD is leading scientific efforts to understand the potential risks to 
human health and the environment from exposure to nanomaterials. In 
2008, ORD created the Nanomaterials Research Strategy document to help 
guide the Agency in answering key science questions regarding the 
source, fate, exposure, risk assessment, and risk management of 
nanomaterials. In 2010, EPA received approximately $18 million for 
nanotechnology research efforts, and ORD had approximately 35 full-time
equivalents4 engaged in both research and grant oversight. ORD plans to 
incorporate nanomaterial research into a broader Chemical Safety and 
Sustainability Research Program. According to ORD, this program is 
intended to combine the use of high-throughput chemical screening and 
prioritization approaches used in other toxicology efforts with ongoing 
nanomaterial research. An ORD representative stated that if the TSCA and 
FIFRA regulatory changes take effect, the additional information that
could be collected would be used to guide ORD’s research efforts as the 
Chemical Safety and Sustainability Research Program evolves into an 
integrated chemicals-related research program. 
Office of Chemical Safety and Pollution Prevention  
OCSPP reviews, regulates, and evaluates the risks of industrial chemicals 
and pesticides sold in and imported into the United States. OCSPP 
currently has approximately five full-time equivalents working on 
nanomaterial activities. Within OCSPP are OPPT and the Office of 
Pesticide Programs (OPP). The primary responsibility of OPPT is to 
implement TSCA and the Pollution Prevention Act. Under these laws, 
EPA evaluates new and existing chemicals and their risks, and finds ways 
to prevent or reduce pollution before it enters the environment. OPPT also 
seeks to promote understanding of chemical risks by providing 
information to the public. OPP is responsible for reviewing and registering 
pesticides under FIFRA. One of OPP’s primary efforts is evaluating 
4 FTE employment is the total number of hours worked, divided by the compensable hours applicable to each fiscal 
year.  There are about 60 ORD scientists who spend some of their time on nanomaterials-related research.
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potential new pesticides. Nanomaterials are currently being included in 
some pesticides. As nanomaterials become more widely used in 
commerce, OPP expects that the need to review different types of 
nanomaterial formulations will increase. 
Other EPA Program Offices
Several other EPA program offices have the statutory authority to regulate 
nanomaterials to address risks posed in the environment. The Office of Air 
and Radiation (OAR), the Office of Solid Waste and Emergency 
Response, and the Office of Water (OW) all have statutory authority to 
regulate nanomaterials in their respective environmental media. 
Additionally, the Office of Enforcement and Compliance Assurance 
(OECA) will have the responsibility to enforce any regulations upon 
enactment. 
Prior Reports 
In the EPA Office of Inspector General (OIG) Report No. 10-P-0066, EPA Needs 
a Coordinated Plan to Oversee Its Toxic Substances Control Act Responsibilities, 
issued February 17, 2010, we found that EPA’s management of chemical risks 
under TSCA was limited by an absence of chemical test data, reliance on risk 
modeling rather than on actual test results, and a lack of transparency. The report 
also stated that oversight of regulatory actions designed to reduce known risks 
was a low priority, and that the resources allocated by EPA were not 
commensurate with the scope of monitoring and oversight work. In addition, we 
found that EPA’s procedures for handling CBI requests were predisposed to 
protect industry information rather than to provide public access to health and 
safety studies. 
The U.S. Government Accountability Office issued Report 10-549, 
Nanomaterials Are Widely Used in Commerce, but EPA Faces Challenges in 
Regulating Risk, in May 2010. This report reviewed the current prevalence of 
nanoscale materials in commerce, discussed the challenges related to regulating 
nanoscale materials, and recommended that EPA utilize the authorities of FIFRA 
and TSCA to regulate nanomaterials.  
Noteworthy Achievements 
EPA has been working to identify the risks that nanomaterials pose to human and 
the environment. In 2005, EPA launched a collaborative public process to design 
and develop the NMSP, and the program was initially implemented in 2008 
NMSP encouraged manufacturers to develop and submit information on 
nanoscale materials that were already in commerce. While EPA’s NMSP did not 
provide the results that the Agency was hoping to achieve, it was a positive step in 
determining how to effectively gather information about nanomaterials. 
12-P-0162      7
    
                                                                                                                                             
 
 
 
 
  
 
 
 
  
 
 
 
 
  
In 2007, EPA published the Nanomaterial White Paper to outline general 
nanomaterial issues for the Agency to focus upon. EPA also published its 
Nanomaterials Research Strategy in 2009, intended to guide ORD’s nanomaterial 
research program. EPA has also been active in sharing information with other 
international organizations, including the Organization for Economic Cooperation 
and Development and the International Organization for Standardization.   
Scope and Methodology 
We conducted this performance evaluation in accordance with generally accepted 
government auditing standards. Those standards require that we plan and perform
the evaluation to obtain sufficient, appropriate evidence to provide a reasonable 
basis for our findings and conclusions based on our objectives. We believe that 
the evidence obtained provides a reasonable basis for our findings and 
conclusions based upon our objectives. We conducted this evaluation from 
October 2010 through September 2011.  
The scope of this evaluation focused on EPA’s responsibilities for oversight, 
assessment, and regulation of nanomaterials. As a result, we interviewed all 
applicable media offices, including OAR, OCSPP, OECA, Office of Solid Waste 
and Emergency Response, and OW. We interviewed the Office of General 
Counsel to determine its assessment of EPA’s statutory authority to regulate 
nanomaterials. We reviewed the American Bar Association analysis of EPA’s 
authority to regulate nanomaterials under TSCA; FIFRA; the Clean Air Act; the 
Clean Water Act; the Comprehensive Environmental Response, Compensation 
and Liability Act; and the Resource Conservation and Recovery Act.  
We conducted interviews at a wide variety of academic institutions, including the 
Smalley Institute for Nanoscale Science and Technology at Rice University, the 
University of Michigan Risk Science Center, and the University of Dublin. We
interviewed representatives of nongovernmental organization such as Resources 
for the Future, the Environmental Defense Fund, and the Silicon Valley Toxics 
Coalition. We also interviewed representatives from the International 
Organization for Standardization and the Organization of Economic Cooperation 
and Development to better understand global aspects of nanomaterial regulation. 
Finally, we reviewed nanomaterial management strategies and regulations from
Canada, the United Kingdom, Australia, and Japan. 
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Chapter 2

EPA Does Not Have Sufficient Information and 

Processes to Effectively Manage Nanomaterial Risks
 
At the time of our review, EPA did not have sufficient information or processes to 
effectively manage the human health and environmental risks of nanomaterials. 
EPA does not have a formal process to coordinate the dissemination and 
utilization of nanomaterial information or communicate nanomaterial risks. EPA 
is not clearly communicating policy changes and the risks of nanomaterials to 
external stakeholders. Also, existing TSCA limitations and resource issues 
challenge EPA’s ability to assess the risks of nanomaterials using its existing 
models. Finally, technological limitations inhibit nanomaterial detection in the 
environment, and a reliance on industry data impedes effective nanomaterial 
management. If these challenges are not resolved, EPA will continue to lack
assurance that it is making effective nanomaterial management decisions.   
Formal Coordination Process Needed to Prioritize Work and Assess 

Nanomaterial Risks 

EPA does not have an Agency-wide, formal process to disseminate manufacturer 
data gathered from TSCA and FIFRA data calls to program offices outside of 
OCSPP. Program offices such as ORD need manufacturer data to prioritize work 
and assess risks. OCSPP staff stated that both OPP and OPPT have established 
relationships with specific individuals in ORD and in the Office of Science Policy 
to guide discussions, share information, and review documents specific to 
nanomaterials. However, this information sharing is not facilitated by a formal 
process; rather, it depends on personal relationships between program office staff. 
Information sharing based on personal relationships can be easily disrupted by 
transfers, travel, retirements, or other personal factors.  
Coordinated sharing of nanomaterial data call information will also be important
if additional regulatory actions become necessary. For instance, OW could use the 
information-gathering provisions of the Clean Water Act to collect information 
about potential effluent discharges containing nanomaterials. While OW has not 
employed this authority, coordination with other offices will be important to 
determine whether and when to employ that authority. Additionally, it will be
important for OECA to effectively enforce regulations to ensure that data 
submission requirements are followed. OECA officials stated that OECA has 
challenges developing enforcement cases for nanomaterials, and must rely heavily 
on OCSPP’s expertise.  
Prior reports have also identified the need for more formal coordination. External 
experts have recommended that the Agency convene a standing intra-Agency 
group to foster information sharing on nanomaterial science and policy issues. In 
12-P-0162      9
    
                                                                                                                                             
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
                                                 
    
 
2007, OCSPP convened such a group, but, according to OCSPP staff, it was 
disbanded in 2008 after only a few meetings. Because of the growing number of 
nanomaterial products entering the marketplace and the anticipated receipt of new 
TSCA and FIFRA data following approval of the requested information-gathering 
rule changes, it will be increasingly necessary for these program offices to 
formally share information and coordinate their efforts. 
EPA Should Improve Communication of Nanomaterial Information to 
the General Public
Through Federal Register notices, program office Web pages, public 
presentations, and meetings, EPA has sought to communicate information related 
to nanomaterials and to gather input from stakeholders. However, the Agency as a 
whole has not provided a transparent overall message about nanomaterials to the 
general public. For some important and/or controversial topics, such as lead 
exposures and hydraulic fracturing, the Agency maintains websites that provide 
an overall picture of the topic, including safety concerns and the Agency’s related 
activities. However, there is no such website for nanomaterials. Several program
offices have nanomaterial-related pages, but these pages only provide information 
related to that particular program’s activities. 
Reports published by the Woodrow Wilson International Center for Scholars in 
2005 and 20095 cautioned that poor public communication of nanomaterial risks 
could threaten the beneficial advancements of the technology and lead to a lack of 
public trust in the government to make the right decisions. The 2005 report 
concluded that the public wants more information in order to make informed 
decisions about nanomaterials. 
The Agency should be prepared to communicate to the public any nonconfidential 
risk information generated or collected through its FIFRA, TSCA, and research 
activities. Because nanomaterials is an emerging issue, it will be important for 
EPA to keep the public informed on the benefits and risks, how the public might 
be exposed, and what regulatory approach the Agency is taking. 
Existing TSCA Limitations Challenge Nanomaterial Management
Nanomaterials will pose additional challenges to EPA’s TSCA programs. As 
identified in a prior OIG report, the EPA New Chemicals Program is limited by 
resources, a lack of information on new chemicals, and its resultant dependence 
on modeling to conduct risk assessments. These shortcomings will be exacerbated 
by the fact that, according to OPPT representatives, the predictive models they 
use for traditional chemicals may not be applicable to nanomaterials. Because 
5 Jane Macoubrie, Informed Public Perceptions of Nanotechnology and Trust in Government, 2005; Dan M. Khan
and David Rejeski, Toward a Comprehensive Strategy for Nanotechnology Risk Communication, 2009. 
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OPPT relies on self-reported data from industry, it may miss chemical risks that 
manufacturers have not disclosed.   
In addition, the 2010 U.S. Government Accountability Office report identified 
several challenges for the Agency in assessing the risks of nanomaterials using its 
existing models. These challenges include the potential for variations in toxicity 
corresponding to small differences in the size, shape, surface area, and reactivity 
of each individual nanomaterial. As a result, accurately assessing any risks of new 
nanomaterials will be difficult for the Agency. 
Limitations in Detection and Assessment Inhibit Effective Management
EPA faces technological limitations in its ability to manage nanomaterials. As 
stated earlier, technology may not currently exist to detect nanomaterials in the 
ambient environment or to remove them if they are found. Thus, the Agency may 
not be able to monitor, identify, and remediate nanomaterial contamination if it 
were to occur in the natural environment. Traditional toxicological screenings for 
nanomaterials are costly and time consuming. According to a senior ORD official, 
traditional toxicological studies for chemicals cost approximately $10 million and 
endure for 5 years. Although more resources are needed, the Agency is in the 
process of testing a new high-throughput screening system called ToxCast,6 
which is intended to allow the Agency to more rapidly assess chemicals 
(including nanomaterials). Given EPA’s resource limitations, potential budget 
cuts, and the findings in our prior TSCA evaluation, the costs associated with 
current methods to develop toxicological data may not be suited for nanomaterial 
data generation. 
Conclusions
EPA does not have sufficient information to determine the risks nanomaterials 
pose to human health and the environment. Without a formal coordination 
process, EPA depends on informal relationships between program office staff to
prioritize nanomaterial research efforts and communicate nanomaterial risks. 
Further, industry stakeholders and the public are not receiving an overall message 
about policy changes or nanomaterial risks. These management issues, combined 
with the challenges of existing TSCA limitations, resource constraints, and 
limitations on technical detection and risk assessment, provide significant barriers 
to effective nanomaterial management. If EPA does not improve its internal 
coordination and develop a clear and consistent stakeholder communication 
process, the Agency will not be able to assure that it is effectively managing 
nanomaterial risks.   
6 EPA launched ToxCast to forecast toxicity using high-throughput screening. This screening examines hundreds of 
thousands of chemicals to identify potential effects. In phase 2 of ToxCast, EPA is testing additional chemicals, 50
to 60 of which will be nanoscale materials. 
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Recommendation 
We recommend that the Assistant Administrator for Chemical Safety and 
Pollution Prevention:
1.		 Develop a process to assure the effective dissemination and coordination 
of nanomaterial information across relevant program offices. 
Agency Comments and OIG Evaluation 
The Agency agreed to our recommendation for a formal process to assure the 
effective dissemination and coordination of nanomaterial information across 
relevant program offices, and provided a corrective action plan with milestone 
dates. The Agency also suggested a revised report title, to which the OIG agreed.  
The Agency also provided additional information regarding OCSPP’s ongoing 
efforts to assess and manage the health and environmental risks of nanomaterials. 
It identified numerous activities to demonstrate nanomaterial-related efforts at the 
intra-Agency, interagency, and intergovernmental levels. The OIG did note most 
of these activities while conducting the evaluation. We added a “Noteworthy 
Achievements” section to chapter 1 of the report, which gives a brief overview of 
these activities. 
EPA did not agree with the OIG finding that the Agency is not clearly 
communicating nanomaterial information to the public. However, the OIG still 
believes that the Agency, as a whole, should provide a transparent overall 
message and could make better use of its website to do so. The OIG believes that 
as the Agency collects and gathers more information and takes further actions on 
nanomaterials, it will be important to keep the public informed of the benefits, 
risks, and potential exposures to nanomaterials, as well as EPA’s regulatory 
approach. The Agency’s detailed response with the OIG’s evaluation is provided 
in appendix A. 
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Status of Recommendations and 
Potential Monetary Benefits 
POTENTIAL MONETARY 
RECOMMENDATIONS BENEFITS (in $000s) 
Rec.
No. 
Page 
No. Subject Status1 Action Official 
Planned 
Completion 
Date 
Claimed 
Amount
Agreed-To 
Amount
1 12 Develop a process to assure the effective 
dissemination and coordination of nanomaterial 
information across relevant program offices.
O Assistant Administrator for 
Office of Chemical Safety
and Pollution Prevention 
07/31/12  
O = recommendation is open with agreed-to corrective actions pending  
C = recommendation is closed with all agreed-to actions completed  
U = recommendation is unresolved with resolution efforts in progress
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Appendix A 
Agency Response and OIG Comment 
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
WASHINGTON, D.C. 20460 
OFFICE OF CHEMICAL SAFETY MEMORANDUM	 AND POLLUTION PREVENTION  
SUBJECT: Response to OIG Draft Report No. OPE-FY11-001: “EPA Cannot Effectively 
Assess or Manage Nanomaterial Risks” 
FROM: Stephen A. Owens 
Assistant Administrator 
TO: 	 Arthur A. Elkins, Jr. 
Inspector General 
This memorandum is in response to the Office of Inspector General’s (OIG) September 30, 2011, 
Draft Report entitled “EPA Cannot Effectively Assess or Manage Nanomaterial Risk.” The 
Office of Chemical Safety and Pollution Prevention (OCSPP) appreciates the opportunity to 
comment on this report. 
While OCSPP recognizes the significant research that was done by the OIG’s staff to prepare the 
Draft Report, the report could be improved by correcting factual errors and by including 
additional information on the substantial efforts that OCSPP already is undertaking to address 
potential health and environmental risks from the use of nanomaterials. I am highlighting several 
key items below, and others are discussed in more detail in the attached technical comments. 
First, the title of the report significantly overstates the actual findings set forth in the body of the 
report, and for that reason, gives a misleading impression about both EPA’s authority over 
nanomaterials and the actions the EPA already has been taking in this area. The title should more 
accurately read, “EPA Needs to Manage Nanomaterial Risks More Effectively,” and we 
respectfully request that the title be changed accordingly. Indeed, the Draft Report contains only 
a single recommendation, which simply states that the Agency should develop a process to 
facilitate the distribution of information regarding nanomaterials across EPA. The current title 
gives the inaccurate impression that EPA does not have authority to oversee nanomaterials, and 
the limited scope of the recommendation and the findings in the Draft Report do not support the  
sweeping declaration in the Draft Report that EPA “cannot effectively… manage nanomaterials.” 
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OIG Response: We changed the report title as suggested. 
There already is an existing process for coordination between OCSPP, the Office of Research 
and Development and other program offices, but OCSPP nevertheless supports the OIG’s 
recommendation that the Agency establish a more formal process. Please see the attached 
Corrective Action Plan for more details on our approach to implementing this recommendation, 
which we believe can be accomplished during fiscal year 2012. 
Additionally, the Draft Report does not discuss actions that the Agency already is taking to 
assess and manage potential health and environmental risks from nanomaterials under both the 
Toxic Substances Control Act (TSCA) and the Federal Insecticide, Fungicide, and Rodenticide 
Act (FIFRA). Information describing the Agency’s efforts, as discussed below, would help 
readers appreciate why the Draft Report’s only recommended corrective action is to establish a 
more formal process for internal agency coordination.  
OIG Response: We understand and acknowledge that the Agency has conducted numerous 
activities in the pursuit of effectively managing nanomaterials as described in OCSPP’s 
response. However, the purpose of this report is to present the result of our evaluation, the 
objective of which was “to determine whether EPA is effectively managing the human health 
and environmental risks of nanomaterials.” As such, we did not find it necessary to include 
many of the details OCSPP has described in this response. To provide better context in our 
report and credit the Agency for steps taken to date, we have added a “Noteworthy 
Achievements” section to chapter 1 of the report. This section gives a brief overview of many 
of the activities listed in OCSPP’s response.    
Further, contrary to the Draft Report’s statement that EPA is “not clearly communicating 
nanomaterial information to the public,” the Agency has taken significant steps to provide 
information, seek public input, and engage the public in general on Agency actions to assess and 
manage potential health and environmental risks from nanomaterials.
Outlined below are some of the significant steps the Agency has taken regarding its oversight of
nanomaterials and to engage and inform stakeholders and the public on these activities. 
OIG Response: The OIG recognizes that EPA offices have made substantial efforts to 
communicate with the public through the many avenues described in OCSPP’s response. In 
chapter 2 of the report, we added a statement recognizing these efforts, and we changed the 
section heading to read, “EPA Should Improve Communication of Nanomaterial Information 
to the General Public.” It remains the OIG’s conclusion that the Agency as a whole should 
provide a more transparent overall message about nanomaterials, and it could better use its 
website to do so. As our report indicates, as the Agency gathers more information and takes 
further actions on nanomaterials, it will be important to keep the American people well 
informed on nanomaterials’ benefits and risks, exposures, and EPA’s regulatory approach. 
12-P-0162      15
    
                                                                                                                                             
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
   
 
 
Intra-agency, Interagency, and Intergovernmental Activities
EPA was an early leader in identifying science and policy issues regarding nanomaterials. In 
December 2004, EPA's Science Policy Council created a cross-Agency workgroup charged with 
describing key science issues EPA should consider to ensure that society accrues the important 
benefits to environmental protection that nanotechnology may offer, as well as to better 
understand any potential risks from exposure to nanomaterials in the environment. EPA released 
an external peer review draft of the Nanotechnology White Paper in December 2005, and in a 
Federal Register notice (70 FR 75812) announced its availability and the opening of a docket for 
public comments. After review and consideration of public comments, EPA's Science Policy 
Council issued the Nanotechnology White Paper in February 2007. The purpose of the White 
Paper was to identify the science issues and needs associated with nanotechnology, to support 
related EPA program office needs, and to communicate these nanotechnology science issues to 
stakeholders and the public. 
OCSPP collaborated closely with the Office of Research and Development (ORD) in the 
development of ORD’s Nanomaterial Research Strategy. As an example of this collaboration, 
OCSPP established a requirement for carbon nanotube premanufacture notices (PMN) that 
companies submit a one-gram sample of their PMN material for inclusion in the ToxCast portion
of ORD’s research on nanomaterials. 
EPA participates in a variety of interagency efforts relating to nanotechnology. For example, 
OCSPP has taken a leadership role in addressing nanotechnology and nanomaterials as a member
of the White House Emerging Technologies Interagency Policy Coordination Committee 
(ETIPC). EPA also was one of the key agencies most involved in the effort by the 
Administration to develop a set of principles for regulation and oversight of nanotechnology 
applications. The principles, entitled “Policy Principles for the U.S. Decision-Making 
Concerning Regulation and Oversight of Nanotechnology and Nanomaterials,” were announced 
in June 2011, after an extensive interagency effort in which EPA played a leading role and are 
intended to guide the development and implementation of the Administration’s regulatory 
approach to nanomaterials and nanotechnology. In addition, in partnership with ORD, OCSPP 
has participated in the interagency Nanotechnology Environmental and Health Implications 
(NEHI) working group, and through the NEHI contributed to both the 2008 and 2011 National 
Nanotechnology Initiative (NNI) strategies for environmental, health, and safety research. 
OCSPP chairs the steering committee of the multi-stakeholder NanoRelease Project, which is 
composed of risk management experts from government, industry, nongovernmental 
organizations, and international organizations. This activity is filling important gaps in our 
knowledge of exposure to nanomaterials, and is focused on:  
 Providing focus to broad policy debates by working through scenarios under which specific 
engineered nanomaterials might be released from products;  
 Examining the full life cycle of products that might act to release nanomaterials; 
 Cataloguing and disseminating published and unpublished data and methods (that meet 
minimum criteria) used to evaluate release scenarios; 
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 Developing “state of the science” reports about release measurement for the specific material 
types chosen that describe what is known and what research gaps exist; and  
 Enabling improvements, standardization, and widespread use of methods by carrying out 
tests using reference nanomaterial-matrix and positive controls in a “round robin” or similar 
approach. 
Coordination and collaboration with the states has been an important element in EPA’s approach 
to nanotechnology. For instance, OCSPP’s Office of Pollution Prevention and Toxics (OPPT) 
interacted closely with the state of California on its carbon nanotube survey activities, including 
participating in a stakeholders’ workshop convened by California agencies. In addition, OCSPP 
and ORD are co-funding a grant to the Environmental Council of the States (ECOS) to support 
activities related to emerging chemicals issues, including nanomaterials.
OCSPP also has played a leadership role in international activities related to nanotechnology. 
OCSPP chaired the OECD’s Working Party on Manufactured Nanomaterials (WPMN) during its 
first program of work, and continues to co-lead the United States delegation to the WPMN. A 
number of OCSPP staff have contributed, and continue to contribute, to several WPMN
activities.
In September 2009, the Assistant Administrator for OCSPP gave the keynote address at an 
international conference on nanotechnology in which he announced EPA’s increased focus on 
potential health and environmental risks from nanomaterials and the Agency’s intention to utilize 
its authority under TSCA and FIFRA more fully to assess and manage those risks. In addition, 
OCSPP staff led the planning and implementation of a 2010 workshop between U.S. and 
European scientists and regulators on nanomaterial science issues, and in 2011 developed a work 
plan with the Canadian government to conduct joint activities related to information and 
assessment needs for our respective nanotechnology-related regulatory and policy activities. 
Activities under TSCA 
Under TSCA, EPA is taking significant actions to ensure that new and existing nanoscale 
materials are reviewed, that information on potential risks is collected and that any necessary risk 
management actions are taken. Since 2005, EPA has received and reviewed over 120 new 
chemical notices under TSCA’s new chemicals program for a variety of new nanoscale 
materials, including carbon nanotubes, fullerenes, quantum dots and nano-metal oxides. The 
Agency has taken a number of actions to control and limit exposures to these chemicals, 
including limiting the uses of the nanoscale materials, requiring the use of personal protective 
equipment, such as impervious gloves and NIOSH approved respirators, limiting environmental 
releases, and requiring testing to generate health and environmental effects data. 
In 2006, EPA launched a collaborative public process to design and develop a voluntary effort, 
the Nanoscale Materials Stewardship Program (NMSP), to help provide a firmer scientific 
foundation for regulatory decisions by encouraging the submission and development of 
information on nanoscale materials already in commerce. The Agency conducted scientific peer 
consultations on risk management practices in October 2006, and on material characterization in 
September 2007 to get public and stakeholder input on the NMSP. In July 2007, EPA announced 
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the availability for public comment of a Concept Paper that outlined the Agency's initial thinking 
on the design and development of the NMSP and conducted a public meeting to obtain additional 
input in August 2007. EPA finalized the design and format of the NMSP based on written public 
comments, and comments received at the public meeting and scientific peer consultations.  
In January 2008, EPA announced the final NMSP and invited interested parties to participate in 
the program. Thirty-one companies or associations submitted information to EPA covering over 
132 nanoscale materials. EPA placed all public versions of NMSP submissions on its TSCA 
nanotechnology webpage. A year later, in January 2009, EPA publicly released a report on the 
NMSP reporting the information it had received. 
Although the NMSP provided EPA with useful information regarding a limited number of 
nanoscale materials in commerce, significant environmental health and safety data gaps remain 
on a number of nanomaterials. Accordingly, in light of the limitations of the NMSP and the need 
to better understand the existing nanomaterials already in commerce, EPA has begun efforts to 
develop new data reporting requirements for nanomaterials under TSCA. EPA’s new approach 
was forecast by OCSPP’s Assistant Administrator in his September 2009 keynote speech, 
including the need to address these data gaps. 
In January 2008, after providing the public and stakeholders an opportunity to review and 
provide comment, EPA released a paper, “TSCA Inventory Status of Nanoscale Substances – 
General Approach (2008),” that outlined EPA's thinking regarding whether a nanoscale material 
is a "new" or "existing" chemical substance under TSCA. In October 2008, EPA published a 
Federal Register notice regarding the TSCA Inventory status of carbon nanotubes which 
indicated that EPA considers carbon nanotubes to be new chemical substances under TSCA, and 
therefore they are subject to review prior to introduction into the marketplace.
In October 2010, the Agency submitted to the Office of Management and Budget (OMB) for 
interagency review a proposed rule under TSCA Section 8(a) to require reporting of certain 
information on nanomaterials by industry and a proposed “significant new use rule” (SNUR) 
under TSCA §5(a)(2). Under these proposals, certain chemical substances with nanomaterials 
not already manufactured would be subject to a SNUR under TSCA §5(a)(2) that would require 
submission of a “significant new use notice” (SNUN) to EPA at least 90 days prior to 
commencing manufacture of these types of materials. The notice would provide EPA with the 
opportunity to evaluate the new use and address any unreasonable risks to human health or the 
environment. Data on other chemical substances with nanomaterials already being manufactured 
would be required to be reported to EPA under TSCA §8(a). These proposals were developed by 
OCSPP after extensive discussions with stakeholders and public outreach. 
Outreach as been integral to OPPT’s nanotechnology activities. OPPT began its TSCA-related 
nanotechnology outreach in 2005, when it convened a public meeting to discuss the regulatory 
implications of manufactured nanomaterials. Later that year, OPPT engaged the National 
Pollution Prevention and Toxics Advisory Committee (NPPTAC) in dialogue concerning 
nanomaterials and TSCA, and later that year held a second public meeting focused on the 
NPPTAC’s recommendations to EPA. Since that time, on regulatory and policy implications of 
nanomaterials for TSCA, OPPT has engaged in numerous outreach activities with many diverse 
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stakeholders, ranging from the Transatlantic Consumer Dialogue to the American Chemistry 
Council to Personal Care Products Council. In addition, OPPT has briefed many other federal 
agencies, congressional staff, and state agencies, as well as interagency and government advisory 
bodies such as ECOS, the NEHI, the President’s Council of Advisors on Science and 
Technology, and the National Academy of Sciences. OPPT also has conducted focused outreach 
for specific programmatic activities, such the NMSP and its draft TSCA significant new use and 
information-reporting rules. In many of these outreach activities, OPPT and ORD staff have 
collaborated and in some cases have given joint presentations, so that communication and 
discussion of the Agency’s nanotechnology-related TSCA activities are conducted with full 
appreciation for the interrelationships between the development of regulatory activities and the 
evolving scientific understanding about the health and environmental implications of 
nanotechnology. 
Activities under FIFRA 
The Agency has also undertaken multiple efforts under FIFRA with respect to the use of 
nanomaterials in pesticides. These efforts can be described in three broad categories relating to 
the development of scientific understanding of risk assessments for nanomaterials in pesticides, 
the development of regulatory policies, and outreach to stakeholders.  
Scientific Policies. Shortly after issuance of the 2005 draft White Paper, OCSPP’s Office of 
Pesticide Programs (OPP) assembled an interdisciplinary team of scientists and regulatory 
specialists to develop policies and procedures for the assessment and regulation of pesticides 
containing nanomaterials. This group participated in intra-agency and interagency activities to 
become familiar with the scientific and regulatory issues facing other regulatory programs. 
In 2009, OPP sought the advice of its FIFRA Scientific Advisory Panel (SAP) on how to assess 
the risk of pesticides containing nanosilver. The SAP is a federal advisory committee that 
includes independent external scientist who provide advice on scientific issues arising in the 
regulation of pesticides. The SAP advised OPP that nanosilver could have different properties 
from ionic or bulk silver and therefore should be separately tested and evaluated.  
Regulatory actions. Consistent with recommendations by the Government Accountability Office 
(GAO) in its 2010 report, in June 2011 EPA published a Federal Register notice proposing a new 
policy on how it will use its authority under FIFRA to oversee and gather information on 
nanoscale materials in pesticide products. In that Notice, the Agency proposed to classify any 
application for registration of a pesticide product containing nanomaterials as an application for a 
“new” active or inert ingredient and described how it could use FIFRA §6(a)(2) or §3(c)(2)(B) to 
gain information on what nanoscale materials are in pesticide products. This Notice generated 
significant public interest. EPA received 159 public submissions, three of which contained 
12,895 letters. The majority of commenters expressed support for EPA’s proposed policies. 
OCSPP has reviewed the public comments and recently submitted a draft final policy to OMB 
for interagency review. 
OPP also is addressing individual pesticide products that contain nanomaterials. OPP has 
received several applications for registration of new products that incorporate various 
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nanomaterials in pesticide products. One of the early applications proposed to register a product 
containing nanosilver for use as a materials preservative on textiles. Following the SAP’s advice, 
OPP developed a draft risk assessment for the pesticide. In 2010 EPA issued its risk assessment 
for public comment as part of its proposed conditional registration of the nanosilver pesticide. 
This was the first time that EPA had proposed to grant registration of a pesticide that explicitly 
contained nanomaterial. The Agency received public comments on the proposed registration 
from a broad spectrum of stakeholders, including private citizens and is in the process of making 
a final decision on the registration.  
In conjunction with its review of this nanosilver pesticide registration application, OPP has been 
working to identify pesticides that contain nanomaterials that were not disclosed to EPA during 
the registration process. EPA’s ability to know which currently registered pesticide actually 
contain nanomaterials would be enhanced by finalization of the FIFRA policy discussed above. 
OPP has also held numerous pre-submission meetings with potential applicants for the 
registration of pesticide products containing nanomaterials. At these meetings, OPP works with 
the companies to ensure they understand Agency’s registration process and the types of 
information and data needed by the Agency to make the required statutory findings to register a 
product. 
Outreach. OPP has solicited extensive and frequent public comment on its actions relating to 
nanomaterials, including at meetings of the Pesticide Program Dialogue Committee (PPDC) (a 
committee consisting of members from academia, industry, non-governmental groups, and state 
governments); the State FIFRA Issues Research and Evaluation Group (SFIREG); and the Tribal 
Pesticide Program Council (TPPC). OPP also given presentations at and participated in 
stakeholder forums to discuss its policy and regulatory thinking on nanomaterials, including, for 
example, the September 2011 International Biocidal Products Directive Conference, the August 
2011 Association of Structural Pest Control Regulatory Officials Conference, the April 2011 
CropLife America meeting, the Responsible Industry for a Sound Environment (RISE) 2011 
Spring Conference, and the May 2011 American Bar Association SEER Nano Governance 
Program Planning Forum. Moreover, EPA presented its draft risk assessment of the nanosilver 
pesticide product at multiple national scientific meetings, including the 2010 Society of 
Environmental Toxicology and Chemistry annual meeting, the December 2010 Society for Risk 
Analysis annual meeting, and the March 2011 American Chemical Society Spring meeting. In 
addition, EPA’s assessment was presented at the May 2011 Joint Special Meeting of The 
Toxicology Forum/Regulatory Governance Initiative: Nanoparticles: Tools for Toxicology.  
Factual Errors About EPA’s TSCA and FIFRA Authority 
Finally, the Draft Report contains several key factual errors that inaccurately characterize EPA’s 
statutory authority under FIFRA and TSCA. For example, the Agency is responsible for 
regulating nanomaterials used in pesticides under FIFRA and in industrial chemicals under 
TSCA. However, the Draft Report incorrectly suggests that EPA has jurisdiction over several 
other uses for nanomaterials, such as foods and drugs, which are expressly excluded from EPA’s 
purview. In addition, the Draft Report does not discuss the fact that EPA’s authority under TSCA 
extends to distribution in commerce, and the use and disposal of nanomaterials, and it fails to 
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discuss EPA’s TSCA authority for new chemicals. Further, the Draft Report does not make clear 
that FIFRA does not authorize the Agency to regulate the manufacturing process for pesticides 
containing nanomaterials, and it inaccurately states that that “several nanomaterials have been 
found to be effective when used as pesticides.” Under FIFRA, EPA has not made any 
determinations on the efficacy of nanomaterial products.  
These errors are discussed in more detail in the attached technical comments, as are other errors 
relating to other aspects of the Agency’s efforts on nanomaterials. 
OIG Response: In the above comments, OCSPP has expressed concerns over an omission 
related to TSCA authority, and the potential for incorrect interpretation of the report language 
related to TSCA and FIFRA jurisdiction. The OIG does not view these as “factual errors.” To 
ensure accurate interpretation of the language in the report, we made changes to the language 
regarding TSCA and FIFRA jurisdiction and FIFRA responsibilities in chapter 1. We also 
removed the statement “several nanomaterials have been found to be effective when used as 
pesticides” to avoid the implication that EPA has made this claim. Additionally, we have 
reviewed and incorporated as appropriate several of the suggested edits provided in OCSPP’s 
detailed “Technical Comments” document. 
Conclusion 
In sum, EPA has been committed for several years to developing and taking action to ensure the 
safe use of nanoscale materials, and to engaging and informing our stakeholders and the public 
on these actions. We believe that recognition of the scope and extent of the Agency’s activities 
regarding nanomaterials, and correction of the factual errors in the Draft Report would put your 
report and its recommendation in better context. 
Thank you again for the opportunity to comment on this Draft Report. OCSPP looks forward to 
working with your office as the report is finalized and the recommendation implemented. If you 
have questions, please feel free to contact Janet Weiner of my staff at (202) 564-2309. 
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Corrective Action Plan for Report No. OPE-FY11-001 
“EPA Cannot Effectively Assess or Manage Nanomaterial Risks” 
11/28/11 
Recommendation to the Assistant Administrator, Office of Chemical Safety and Pollution 
Prevention: Develop a process for dissemination and coordination of nanomaterials information 
across relevant program offices. 
Specific Recommendation Corrective Action Target Date 
Develop a process to assure 
the effective dissemination 
and coordination of 
nanomaterials information 
across relevant program
offices. 
By January 31, 2012, convene 
a workgroup consisting of 
representatives from all 
relevant offices to begin 
development of process. 
Complete draft document 
outlining process.
January 31, 2012 
July 31, 2012 
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Appendix B 
Distribution 
Office of the Administrator  
Deputy Administrator 
Acting Assistant Administrator for Chemical Safety and Pollution Prevention 
Agency Follow-Up Coordinator  
Agency Follow-Up Official (the CFO) 
General Counsel 
Associate Administrator for Congressional and Intergovernmental Relations   
Associate Administrator for External Affairs and Environmental Education  
Director, Office of Children’s Health Protection and Environmental Education 
Audit Follow-Up Coordinator, Office of Chemical Safety and Pollution Prevention 
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